Carole Masurier

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

Joseph Wolfers, Anne Lozier, Graça Raposo et al. · Nature Medicine · 2001 · 1.6K citations

Ctl Cross-priming, Tumor Immunology, Cancer Immunosurveillance +14

Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors

Sylvie Boutin, Virginie Monteilhet, P. Véron et al. · Human Gene Therapy · 2010 · 922 citations

Vaccination, Molecular Virology, Allergy +12

Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy

Caroline Le Guiner, Laurent Servais, Marie Montus et al. · Nature Communications · 2017 · 230 citations · Full text

A 10 Patient Case Report on the Impact of Plasmapheresis Upon Neutralizing Factors Against Adeno-associated Virus (AAV) Types 1, 2, 6, and 8

Virginie Monteilhet, Samir Saheb, Sylvie Boutin et al. · Molecular Therapy · 2011 · 193 citations · Full text

Gene Therapy Prolongs Survival and Restores Function in Murine and Canine Models of Myotubular Myopathy

Martin K. Childers, Romain Joubert, Karine Poulard et al. · Science Translational Medicine · 2014 · 168 citations